Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.2 USD | +4.48% | +3.23% | +29.33% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.33% | 2.3B | |
+9.97% | 3,074B | |
+5.95% | 83.22B | |
+4.71% | 77.61B | |
-16.04% | 52.63B | |
+46.83% | 56.14B | |
-23.58% | 47.31B | |
+26.96% | 44.65B | |
+63.28% | 37.98B | |
-12.27% | 25.66B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- BofA Securities Starts Cellebrite DI at Buy with $11 Price Target